Menu
Cart 0
Biosimulation Market

Biosimulation Market - Forecasts from 2017 to 2022

  • $4,200.00
  • Publishing Date: January 2017
  • Format: PDF
Sample Request

Biosimulation is used in the healthcare sector for model-based calculation of biological systems. It is helpful in making commercial decisions regarding the benefits of bringing a specific drug to market. In 2022, the market for biosimulation is expected to reach US$3,435 million, increasing from US$1,476 million in 2017. During this period, it is projected to grow at a CAGR of 18.40%. Factors driving the biosimulation market growth are increased medical research and development across emerging economies, technological advancement in drug development processes, robust pace of clinical trials and a favorable regulatory environment in developed regions like the US and Europe. Rising demand for reduced drug development costs coupled with penetration of digital and computer technology and improvement in modeling tools has fuelled further market growth. Geographically, North America is the expected to remain the largest biosimulation market over the projected period followed by Europe.

Research Methodology

The first section of the report deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentations which have been covered as part of the report.

Market Dynamics

Next section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook, key industry and regional regulations which are determining the product specifications and a brief technological aspect of Biosimulation. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section.

Segmentation

The Biosimulation market has been segmented by type, applications, end-user industry and geography.

  • By Type:
    • Software
    • Services
  • By Application:
    • Drug Development
    • Drug Discovery
    • Others
  • By End-User Industry:
    • Pharmaceutical Companies
    • Academic Institutions
    • Research Organizations
    • Others
  • By Geography:
    • Americas
      • North America
      • South America
    • Europe Middle East & Africa
      • Europe
      • The Middle East & Africa
    • Asia Pacific

Market Players

Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players in the Biosimulation market are Certara USA, Inc., Advanced Chemistry Development, Inc., Schrodinger, LLC and Simulations Plus among others.

1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. MARKET OVERVIEW AND SEGMENTATION
4.1.1. OVERVIEW
4.1.2. SEGMENTATION
4.2. DRIVERS
4.2.1. FOCUS ON POPULATION HEALTH MANAGEMENT
4.2.2. REDUCTION IN THE AMOUNT SPENT ON PHYSICAL DRUG DEVELOPMENT
4.2.3. TIME REDUCTION FOR DRUG DEVELOPMENT
4.2.4. INCREASING USE OF BIOLOGICALS AND GENERICS
4.3. RESTRAINTS
4.3.1. INACCURACY IN PREDICTION
4.3.2. LACK OF SKILLED WORKFORCE
4.3.3. LOWER ADOPTION BY SOME OF THE FAST-GROWING ECONOMIES
4.4. OPPORTUNITIES
4.4.1. DRUG DEVELOPMENT
4.4.2. ASIA PACIFIC REGION
4.5. SUPPLIER OUTLOOK
4.6. INDUSTRY OUTLOOK
4.7. PORTER’S 5 FORCES ANALYSIS
4.7.1. BARGAINING POWER OF SUPPLIERS
4.7.2. BARGAINING POWER OF CONSUMERS
4.7.3. THREAT OF NEW ENTRANTS
4.7.4. THREAT OF SUBSTITUTES
4.7.5. COMPETITIVE RIVALRY WITHIN THE INDUSTRY
4.8. INDUSTRY VALUE CHAIN ANALYSIS
4.9. SCENARIO ANALYSIS
5. BIOSIMULATION MARKET FORECAST BY TYPE (US$ MILLION)
5.1. SOFTWARE
5.1.1. OVERVIEW
5.1.2. BIOSIMULATION MARKET, SOFTWARE, BY REGION
5.2. SERVICES
5.2.1. OVERVIEW
5.2.2. BIOSIMULATION MARKET, SERVICES, BY REGION
6. BIOSIMULATION MARKET FORECAST BY APPLICATION (US$ MILLION)
6.1. DRUG DEVELOPMENT
6.1.1. OVERVIEW
6.1.2. BIOSIMULATION MARKET, DRUG DEVELOPMENT, BY REGION
6.2. DRUG DISCOVERY
6.2.1. OVERVIEW
6.2.2. BIOSIMULATION MARKET, DRUG DISCOVERY, BY REGION
6.3. OTHERS
6.3.1. OVERVIEW
6.3.2. BIOSIMULATION MARKET, OTHERS, BY REGION
7. BIOSIMULATION MARKET FORECAST BY END-USER  (US$ MILLION)
7.1. PHARMACEUTICAL COMPANIES
7.1.1. OVERVIEW
7.1.2. BIOSIMULATION MARKET, PHARMACEUTICAL COMPANIES, BY REGION
7.2. ACADEMIC INSTITUTIONS
7.2.1. OVERVIEW
7.2.2. BIOSIMULATION MARKET, ACADEMIC INSTITUTIONS, BY REGION
7.3. RESEARCH ORGANIZATIONS
7.3.1. OVERVIEW
7.3.2. BIOSIMULATION MARKET, RESEARCH ORGANIZATIONS, BY REGION
7.4. OTHERS
7.4.1. OVERVIEW
7.4.2. BIOSIMULATION MARKET, OTHERS, BY REGION
8. BIOSIMULATION MARKET FORECAST BY GEOGRAPHY (US$ MILLION)
8.1. AMERICAS
8.1.1. NORTH AMERICA
8.1.1.1. BIOSIMULATION MARKET, NORTH AMERICA, BY TYPE
8.1.1.2. BIOSIMULATION MARKET, NORTH AMERICA, BY APPLICATION
8.1.1.3. BIOSIMULATION MARKET, NORTH AMERICA, BY END-USER 
8.1.2. SOUTH AMERICA
8.1.2.1. BIOSIMULATION MARKET, SOUTH AMERICA, BY TYPE
8.1.2.2. BIOSIMULATION MARKET, SOUTH AMERICA, BY APPLICATION
8.1.2.3. BIOSIMULATION MARKET, SOUTH AMERICA, BY END-USER 
8.2. EUROPE MIDDLE EAST AND AFRICA
8.2.1. EUROPE
8.2.1.1. BIOSIMULATION MARKET, EUROPE, BY TYPE
8.2.1.2. BIOSIMULATION MARKET, EUROPE, BY APPLICATION
8.2.1.3. BIOSIMULATION MARKET, EUROPE, BY END-USER 
8.2.2. MIDDLE EAST AND AFRICA
8.2.2.1. BIOSIMULATION MARKET, MIDDLE EAST AND AFRICA, BY TYPE
8.2.2.2. BIOSIMULATION MARKET, MIDDLE EAST AND AFRICA, BY APPLICATION
8.2.2.3. BIOSIMULATION MARKET, MIDDLE EAST AND AFRICA, BY END-USER 
8.3. ASIA PACIFIC
8.3.1. BIOSIMULATION MARKET, ASIA PACIFIC, BY TYPE
8.3.2. BIOSIMULATION MARKET, ASIA PACIFIC, BY APPLICATION
8.3.3. BIOSIMULATION MARKET, ASIA PACIFIC, BY END-USER 
9. COMPETITIVE INTELLIGENCE
9.1. MARKET SHARE OF KEY PLAYERS
9.2. INVESTMENT ANALYSIS
9.3. RECENT DEALS
9.4. STRATEGIES OF KEY PLAYERS
10. COMPANY PROFILES
10.1. CERTARA USA, INC.
10.1.1. OVERVIEW
10.1.2. FINANCIALS
10.1.3. PRODUCTS AND SERVICES
10.1.4. RECENT DEVELOPMENTS
10.2. ADVANCED CHEMISTRY DEVELOPMENT, INC.
10.2.1. OVERVIEW
10.2.2. FINANCIALS
10.2.3. PRODUCTS AND SERVICES
10.2.4. RECENT DEVELOPMENTS
10.3. SCHRODINGER, LLC
10.3.1. OVERVIEW
10.3.2. FINANCIALS
10.3.3. PRODUCTS AND SERVICES
10.3.4. RECENT DEVELOPMENTS
10.4. SIMULATIONS PLUS, INC.
10.4.1. OVERVIEW
10.4.2. FINANCIALS
10.4.3. PRODUCTS AND SERVICES
10.4.4. RECENT DEVELOPMENTS
10.5. CHEMICAL COMPUTING GROUP INC.
10.5.1. OVERVIEW
10.5.2. FINANCIALS
10.5.3. PRODUCTS AND SERVICES
10.5.4. RECENT DEVELOPMENTS
10.6. DASSAULT SYSTEMES BIOVIA
10.6.1. OVERVIEW
10.6.2. FINANCIALS
10.6.3. PRODUCTS AND SERVICES
10.6.4. RECENT DEVELOPMENTS
10.7. IN SILICO BIOSCIENCES, INC.
10.7.1 OVERVIEW
10.7.2. FINANCIALS
10.7.3. PRODUCTS AND SERVICES
10.7.4. RECENT DEVELOPMENTS
10.8. INHIBOX LTD
10.8.1. OVERVIEW
10.8.2. FINANCIALS
10.8.3. PRODUCTS AND SERVICES
10.8.4. RECENT DEVELOPMENTS
10.9. LEADINVENT TECHNOLOGIES PVT. LTD.
10.9.1. OVERVIEW
10.9.2. FINANCIALS
10.9.3. PRODUCTS AND SERVICES
10.9.4. RECENT DEVELOPMENTS
10.10. GENEDATA AG
10.10.1. OVERVIEW
10.10.2. FINANCIALS
10.10.3. PRODUCTS AND SERVICES
10.10.4. RECENT DEVELOPMENTS
10.11. PHYSIOMICS PLC
10.11.1. OVERVIEW
10.11.2. FINANCIALS
10.11.3. PRODUCTS AND SERVICES
10.11.4. RECENT DEVELOPMENTS

11. LIST OF TABLES
12. LIST OF FIGURES
13. DISCLAIMER

List of Tables

Table 1: Biosimulation Market Forecast, 2017 to 2022, US$ million

Table 2: Biosimulation Market Forecast, 2017 to 2022, By Type, US$ million

Table 3: Biosimulation Market Forecast, 2017 to 2022, By Type, Software, By Region, US$ million

Table 4: Biosimulation Market Forecast, 2017 to 2022, By Type, Services, By Region, US$ million

Table 5: Biosimulation Market Forecast, 2017 to 2022, By Application, US$ million

Table 6: Biosimulation Market Forecast, 2017 to 2022, By Application, Drug Development, By Region, US$ million

Table 7: Biosimulation Market Forecast, 2017 to 2022, By Application, Drug Discovery, By Region, US$ million

Table 8: Biosimulation Market Forecast, 2017 to 2022, By Application, Others, By Region, US$ million

Table 9: Biosimulation Market Forecast, 2017 to 2022, By End-User, US$ million

Table 10: Biosimulation Market Forecast, 2017 to 2022, By End-User, Pharmaceutical Companies, By Region, US$ million

Table 11: Biosimulation Market Forecast, 2017 to 2022, By End-User, Academic Institutes, By Region, US$ million

Table 12: Biosimulation Market Forecast, 2017 to 2022, By End-User, Research Organizations, By Region, US$ million

Table 13: Biosimulation Market Forecast, 2017 to 2022, By End-User, Others, By Region, US$ million

Table 14: Biosimulation Market Forecast, 2017 to 2022, By Region, US$ million

Table 15: Biosimulation Market Forecast, 2017 to 2022, By Region, Americas, US$ million

Table 16: Biosimulation Market Forecast, 2017 to 2022, By Region, Europe Middle East and Africa, US$ million

Table 17: Biosimulation Market Forecast, 2017 to 2022, By Region, Asia Pacific, US$ million

Table 18: Biosimulation Market Forecast, 2017 to 2022, By Type, North America, US$ million

Table 19: Biosimulation Market Forecast, 2017 to 2022, By Application, North America, US$ million

Table 20: Biosimulation Market Forecast, 2017 to 2022, By End User, North America, US$ million

Table 21: Biosimulation Market Forecast, 2017 to 2022, By Type, South America, US$ million

Table 22: Biosimulation Market Forecast, 2017 to 2022, By Application, South America, US$ million

Table 23: Biosimulation Market Forecast, 2017 to 2022, By End User, South America, US$ million

Table 24: Biosimulation Market Forecast, 2017 to 2022, By Type, Europe, US$ million

Table 25: Biosimulation Market Forecast, 2017 to 2022, By Application, Europe, US$ million

Table 26: Biosimulation Market Forecast, 2017 to 2022, By End User, Europe, US$ million

Table 27: Biosimulation Market Forecast, 2017 to 2022, By Type, Middle East and Africa, US$ million

Table 28: Biosimulation Market Forecast, 2017 to 2022, By Application, Middle East and Africa, US$ million

Table 29: Biosimulation Market Forecast, 2017 to 2022, By End User, Middle East and Africa, US$ million

Table 30: Biosimulation Market Forecast, 2017 to 2022, By Type, Asia Pacific, US$ million

Table 31: Biosimulation Market Forecast, 2017 to 2022, By Application, Asia Pacific, US$ million

Table 32: Biosimulation Market Forecast, 2017 to 2022, By End User, Asia Pacific, US$ million


Related Reports
Back to the top